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Abstract
Synchronous composite tumors though described are uncommon. Moreover, simultaneous
occurrence of synchronous tumors involving the same tissue or organ at multiple sites is even less
common. We report a case of acute lymphoblastic leukemia (ALL) and basal cell carcinoma (BCC)
occurring simultaneously in multiple skin sites. Several cases showing an association between
cutaneous malignancies and lymphoproliferative disorders have been reported. Some of these cases
included ALL and BCC and occurred often in the pediatric population with the BCC arising as a
post-ALL therapy sequela. Other rare genetic causes may be considered. To our knowledge this is
the first time that the synchronous occurrence of these two malignant processes in the same tissue
involving multiple sites in an elderly patient is described.
Background
Composite malignancies are an interesting phenomenon
that gives rise to questions related to etiologies, diagnostic
implications, and treatment. We present an interesting
case of a composite multifocal acute lymphoblastic leuke-
mia (ALL) and basal cell carcinoma (BCC). Independently
the two malignancies occur in two opposite extremes of
age and their occurrence as a composite tumor is
extremely unusual. In fact, to the best of our knowledge,
composite ALL and BCC has never been reported before in
the English literature.
Case presentation
Clinical summary
A previously healthy 76 year-old caucasian man presented
with multiple slowly growing translucent tan and pink
skin patches and nodules, involving the left upper limb,
right supraclavicular fossa and the posterior surface of the
right ear. These lesions showed ill-defined borders and
were of variable sizes, which ranged from 1 cm to 3.5 cm
in maximum dimension. Skin ulceration, lymphadenop-
athy and organomegaly were absent. Clinically, the skin
lesions were diagnosed as BCC and were treated by wide
excision.
Pathological findings
Pathology confirmed the presence of multiple BCCs and
in addition the three biopsy sites showed diffuse infiltra-
tion of the dermis by large, atypical cells with blastic mor-
phology and displaying perineural and perivascular
accentuation (Fig. 1, 2). Occasional tumor vascular
emboli were noted (Fig. 3). In addition, dense infiltrates
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of small mature lymphocytes were noted inbetween the
invasive solid masses of BCC. A wide panel of immuno-
histochemistry was performed (Table 1 and fig. 3, 4, 5, 6,
7, 8) and accordingly the case was diagnosed as composite
multifocal BCC and precursor B acute-ALL. Consequently,
the patient was fully investigated. The peripheral blood
showed a leukoerythroblastic picture. The bone marrow
revealed pancytopenia and acute leukemia with a blast
count greater than 20%. Flow cytometry results confirmed
the diagnosis of precursor B-ALL. The patient received
induction chemotherapy with high dose cyclophospha-
mide under mesna cover, doxorubicin, vincristine and
high dose dexamethasone. A month and a half later he
was readmitted and received methotrexate with leucov-
orin rescue and high dose cytosine arabinoside. Follow up
for 2 years shows the patient to be still in remission.
Discussion
Composite double malignancies involving similar and
multiple locations are extremely rare. Such tumors usually
occur in a setting of immune deficiency or a genetic pre-
disposition. BCC and ALL are two tumors that affect dif-
ferent age groups with the former almost always occurring
in elderly and the latter in children. ALL associated with
metachronous but not synchronous BCC has been
reported [1-3]. Such cases occurred in children who
received radiotherapy as part of the treatment protocol of
ALL and as a possible consequence of BCC. Similar cases
of BCC have been reported after radiotherapy for brain
tumors [4]. It is not surprising that such cases occurred in
children, as 88% of patients with ALL are under 35 years
of age with a median age of 20 years [5]. On the other
hand, BCC are extremely rare in children with 45 case
reports of BCCs in children aged 15 years or younger [6].
The occurrence of BCC is possibly a result of an ionizing
"radiation induced" complication. The other but less
likely etiological factor underlying the occurrence of the
two tumors is ionizing radiation associated BCC in
patients with nevoid BCC syndrome (NBCCS) or a spo-
radic BCC. NBCCS is an autosomal dominant disorder
with a high degree of penetrance and variable expressivity,
and is characterized by BCC, odontogenic keratocysts, pal-
mar and/or plantar pits, and ectopic calcifications of the
falx cerebri. More than 100 minor criteria have been
described, but 2 major and 1 minor criterion or 1 major
and 3 minor criteria are necessary for the diagnosis. The
median interval between ionizing radiation induced BCC
and X-ray exposure is greater than 20 years in older
patients, however this interval may be as short as 3–5
years in younger patients [7]. To the best of our knowl-
edge, composite multifocal ALL and BCC has never been
reported before in the English literature. In the present
case, the absence of any prior history of radiotherapy or
immune deficiency and the mere occurrence in a previ-
ously healthy adult suggest a coincidental but unusual
occurrence of composite tumors.
In our case, the presence of a dermal vasocentric undiffer-
entiated large cell tumor in a setting of BCC occurring in
an adult raised the differential of several hematological
malignancies such as granulocytic sarcoma, acute myeloid
leukemia, blastoid mantle cell lymphoma, ALL, and
Burkitt's lymphoma, though the latter two tumors show a
predilection for young age. In addition solid tumors such
as neuroblastoma, malignant melanoma and Merkel cell
carcinoma were also included. As the tumor was not in
bone marrow and involved an elderly patient without a
previous history of chemo- or radiotherapy, there was no
consideration of haematogones in the differential diagno-
sis. With the aid of immunohistochemistry, the tumor
was diagnosed as precursor B-ALL. Although skin involve-
ment with B-ALL is frequent, it is interesting that this
Table 1: Immunohistochemical profiles of the two composite tumors
Marker Basal cell carcinoma Mature looking lymphocytes Precursor B cell acute 
lymphoblastic leukemia
BER EP4 Diffusely Positive Negative Negative
TdT Negative Negative Diffusely Positive
CD 10 Diffusely Positive Negative Diffusely Positive
CD 43 Negative Diffusely Positive Diffusely Positive
CD 79a Negative Negative Diffusely Positive
Bcl-2 Negative Diffusely Positive Diffusely Positive
LCA (CD 45) Negative Diffusely Positive Diffusely Positive
CD 34 Negative Negative Diffusely Positive
Myeloperioxidase Negative Negative Negative
CD 117 Negative Negative Weakly Positive (<10%)
CD 99 Negative Negative Weakly Positive (<10%)
CD 3 Negative Diffusely Positive Negative
CD 5 Negative Diffusely Positive Negative
CD 7 Negative Diffusely Positive Negative
Ki 67 index 5% 0% 30–40%Diagnostic Pathology 2007, 2:32 http://www.diagnosticpathology.org/content/2/1/32
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Dermal infiltration by basal cell carcinoma and lymphoblastic lymphoma Figure 1
Dermal infiltration by basal cell carcinoma and lymphoblastic lymphoma. The latter extends to involve the deeper dermis with 
peri-vascular accentuation (HE 40×).
Skin with basal cell carcinoma showing continuity with the overlying epidermis and intervening dermis infiltrated by large blasts  of acute lymphoblastic lymphoma (HE 100×) Figure 2
Skin with basal cell carcinoma showing continuity with the overlying epidermis and intervening dermis infiltrated by large blasts 
of acute lymphoblastic lymphoma (HE 100×).Diagnostic Pathology 2007, 2:32 http://www.diagnosticpathology.org/content/2/1/32
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Restricted expression of TdT within the lymphocytes in lymphoblastic lymphoma in contrast to basal cell carcinoma cells (TdT  100×) Figure 3
Restricted expression of TdT within the lymphocytes in lymphoblastic lymphoma in contrast to basal cell carcinoma cells (TdT 
100×).
Restricted expression of CD79a within the lymphocytes in lymphoblastic leukemia in contrast to basal cell carcinoma (CD79a  100×) Figure 4
Restricted expression of CD79a within the lymphocytes in lymphoblastic leukemia in contrast to basal cell carcinoma (CD79a 
100×).Diagnostic Pathology 2007, 2:32 http://www.diagnosticpathology.org/content/2/1/32
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Expression of CD3 within reactive mature looking T lymphocytes and absence of staining in both lymphoblastic lymphoma and  basal cell carcinoma (CD3 100×) Figure 5
Expression of CD3 within reactive mature looking T lymphocytes and absence of staining in both lymphoblastic lymphoma and 
basal cell carcinoma (CD3 100×).
Simultaneous expression of CD10 within the lymphocytes in lymphoblastic lymphoma and basal cell carcinoma cells (CD10  400×) Figure 6
Simultaneous expression of CD10 within the lymphocytes in lymphoblastic lymphoma and basal cell carcinoma cells (CD10 
400×).Diagnostic Pathology 2007, 2:32 http://www.diagnosticpathology.org/content/2/1/32
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Expression of CD34 within lymphocytes in lymphoblastic leukemia, native epidermis and dermal vessels and absence of stain- ing in basal cell carcinoma (CD34 100×) Figure 7
Expression of CD34 within lymphocytes in lymphoblastic leukemia, native epidermis and dermal vessels and absence of stain-
ing in basal cell carcinoma (CD34 100×).
Restricted expression of Bcl-2 within the lymphocytes in lymphoblastic leukemia and reactive T lymphocytes in contrast to  basal cell carcinoma cells (Bcl-2 100×) Figure 8
Restricted expression of Bcl-2 within the lymphocytes in lymphoblastic leukemia and reactive T lymphocytes in contrast to 
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patient presented initially with a skin manifestation with
multifocal BCC rather than the usual manifestations of
ALL such as bone marrow failure, hepatosplenomegaly, or
lymphadenopathy. The findings of pancytopenia and
marrow failure were discovered only later.
In conclusion we report an unusual case of composite
multifocal precursor B-ALL and BCC. To the best of our
knowledge this is the first case report in the English litera-
ture of the synchronous multifocal occurrence of these
tumors in an adult. The case presented here emphasizes
the value of awareness of composite tumors. The aware-
ness of occurrence of composite tumors is crucial so that
the patient can receive adequate therapy. Consideration of
tumors in the differential diagnosis that fit the morphol-
ogy but not the usual demographic profile, even in the
absence of clinical suspicion, is a safe practice if accompa-
nied by further ancillary studies to document or rule them
out.
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